The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...

We came across a bullish thesis on Teva Pharmaceutical Industries Limited on Kontra Investments’ Substack by Kontra. In this ...

One lot of reflux medicine got recalled when fluid retention tablets were discovered in the medicine bottles.

Today, Teva Pharmaceutical Industries (TASE: TEVA; NYSE: TEVA) announced the launch of a technological innovation program in drug development, at an investment expected to reach tens of millions of ...

Teva Pharmaceutical has reported the final analysis of the PEARL Phase IV migraine prevention trial of Ajovy (fremanezumab).

Prevention editors also consider Brooks and Asics sneakers a top brand choice for walking or running on concrete. Several ...

Despite the popularity of generic and biosimilar drugs in Europe—the latter of which have struggled to catch on in the ...

Billionaire investment legend Stanley Druckenmiller is quickly becoming one of my favorite big-money managers to follow ...

Teva Pharmaceutical Industries (NYSE:TEVA) Upsizes Senior Notes Offering to US$2.3 Billion Teva Pharmaceutical Industries (NYSE:TEVA) recently made headlines by upsizing its senior notes offering to ...

Two and a half years into his tenure as Teva’s CEO, Richard Francis is breaking down the strategy that’s powered the company ...

Final results from the Phase IV PEARL trial show that 66% of patients treated with Ajovy for episodic migraine and more than ...